---
title: "BTIG Remains a Buy on Kestra Medical Technologies Ltd. (KMTS)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292619992.md"
description: "BTIG analyst Marie Thibault maintains a Buy rating on Kestra Medical Technologies Ltd. (KMTS) with a $30 price target, noting the stock closed at $25.99. The analyst consensus is also a Moderate Buy with an average target of $30. Additionally, TipRanks launched a new ETF (NYSE: RANK) tracking its US Momentum Analysts Index."
datetime: "2026-07-14T11:26:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292619992.md)
  - [en](https://longbridge.com/en/news/292619992.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292619992.md)
generator: "portal-rs"
---

# BTIG Remains a Buy on Kestra Medical Technologies Ltd. (KMTS)

In a report released on July 10, Marie Thibault from BTIG maintained a Buy rating on Kestra Medical Technologies Ltd., with a price target of $30.00. The company’s shares closed yesterday at $25.99.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Thibault is an analyst with an average return of -12.6% and a 35.94% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Irhythm Technologies, Insulet, and Dexcom.

Currently, the analyst consensus on Kestra Medical Technologies Ltd. is a Moderate Buy with an average price target of $30.00.

### Related Stocks

- [KMTS.US](https://longbridge.com/en/quote/KMTS.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [IRTC.US](https://longbridge.com/en/quote/IRTC.US.md)
- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)
- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)

## Related News & Research

- [Kestra Medical Technologies (KMTS) Puts Customer Experience In Focus As Valuation Debate Builds](https://longbridge.com/en/news/298240584.md)
- [Kestra Medical CEO Brian Daniel Webster sells 15,000 common shares for $412,180.50](https://longbridge.com/en/news/296277214.md)
- [RealReal management to meet with BTIG](https://longbridge.com/en/news/298159892.md)
- [BlackRock buys 18 Exail Technologies shares at EUR 124.3 during pre-offer period](https://longbridge.com/en/news/298215124.md)
- [Wildcat Resources Ltd. (WC8) Receives a Buy from Shaw and Partners](https://longbridge.com/en/news/297627932.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**